Mursla Company

Novel integrated platform for the discovery and profiling of exosome phenotypes in diseases.
Technology: AgeTech Companies
Industry: Deep diagnostics
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Founded Date: 2019-03-01
Employees Number: 1-10
Funding Status: Seed
Total Funding: $750,000.00
Estimated Revenue: $1M to $10M
Last Funding Type: Undisclosed

Visit Website
Register and Claim Ownership